Satori Pharmaceuticals, Inc. Garners $22,000,000 Series B Financing Round

  • Feed Type
  • Date
    1/8/2009
  • Company Name
    Satori Pharmaceuticals, Inc.
  • Mailing Address
    222 Berkeley Street Boston, MA 02116
  • Company Description
    Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders.
  • Website
    http://www.satoripharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    PureTech Ventures

By posting a comment, you agree to our terms and conditions.